Historical Stock Price
ETFs Holding AMGN »    AMGN Split History »
Video: Compound Annual Growth Rate (CAGR) Definition


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Date Open High Low Close Volume
08/04/2022 $247.00 $249.00 $246.20 $246.98 2.65M
08/05/2022 $246.46 $247.08 $241.79 $246.25 2.72M
08/08/2022 $245.00 $247.74 $244.31 $247.29 2.78M
08/09/2022 $247.21 $249.72 $247.21 $248.36 2.06M
08/10/2022 $249.81 $252.46 $248.53 $252.09 2.63M
Amgen is a biotechnology company that focuses on discovering, developing, manufacturing and delivering human therapeutics. Co.'s principal products are Enbrel® (etanercept), Prolia® (denosumab), Otezla® (apremilast), XGEVA® (denosumab), Neulasta® (pegfilgrastim), Aranesp® (darbepoetin alfa), Repatha® (evolocumab), KYPROLIS® (carfilzomib) and Nplate® (romiplostim). Co. also markets a number of other products, including among other, MVASI® (bevacizumab-awwb), Vectibix® (panitumumab), KANJINTI® (trastuzumab-anns), EVENITY® (romosozumab-aqqg), EPOGEN® (epoetin alfa), BLINCYTO® (blinatumomab), AMGEVITA™ (adalimumab), Aimovig® (erenumab-aooe), Parsabiv® (etelcalcetide) and NEUPOGEN® (filgrastim).
AMGN historical stock prices picture
Amgen (AMGN) has the following price history information. Looking back at AMGN historical stock prices for the last five trading days, on August 04, 2022, AMGN opened at $247.00, traded as high as $249.00 and as low as $246.20, and closed at $246.98. Trading volume was a total of 2.65M shares. On August 05, 2022, AMGN opened at $246.46, traded as high as $247.08 and as low as $241.79, and closed at $246.25. Trading volume was a total of 2.72M shares. On August 08, 2022, AMGN opened at $245.00, traded as high as $247.74 and as low as $244.31, and closed at $247.29. Trading volume was a total of 2.78M shares. On August 09, 2022, AMGN opened at $247.21, traded as high as $249.72 and as low as $247.21, and closed at $248.36. Trading volume was a total of 2.06M shares. On August 10, 2022, AMGN opened at $249.81, traded as high as $252.46 and as low as $248.53, and closed at $252.09. Trading volume was a total of 2.63M shares.

AMGN Historical Stock Prices By Date:

AMGN historical cagr picture

Below, we examine the compound annual growth rate — CAGR for short — of an investment into Amgen shares, starting with a $10,000 purchase of AMGN, and working forward through the historical stock price information to today.

Growth of $10,000.00
With Dividends Reinvested

Start date: 08/14/2012
End date: 08/10/2022
Start price/share: $83.54
End price/share: $252.09
Starting shares: 119.70
Ending shares: 154.05
Dividends reinvested/share: $45.20
Total return: 288.35%
Average Annual Total Return: 14.54%
Starting investment: $10,000.00
Ending investment: $38,837.27
Years: 9.99
 
Growth of $10,000.00
Without Dividends Reinvested

Start date: 08/14/2012
End date: 08/10/2022
Start price/share: $83.54
End price/share: $252.09
Dividends collected/share: $45.20
Total return: 255.87%
Average Annual Total Return: 13.54%
Starting investment: $10,000.00
Ending investment: $35,578.42
Years: 9.99
Date Close
08/04/2022$246.98
08/05/2022$246.25
08/08/2022$247.29
08/09/2022$248.36
08/10/2022$252.09
AMGN is categorized under the Healthcare sector; below are some other companies in the same sector:

AMN Historical Stock Prices
AMPE Historical Stock Prices
AMPH Historical Stock Prices
AMRI Historical Stock Prices
AMRN Historical Stock Prices
AMRX Historical Stock Prices
AMS Historical Stock Prices
AMSG Historical Stock Prices
AMTI Historical Stock Prices
ANAB Historical Stock Prices

Also explore: AMGN shares outstanding history

Email EnvelopeFree AMGN Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

AMGN Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2022, All Rights Reserved

Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.